WHO ICTRP trial
Effect of human neural stem cells on patients with moderate to severe…
ChiCTR2000039011 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2000039011 |
|---|---|
| Public title | Effect of human neural stem cells on patients with moderate to severe early-onset Alzheimer's disease clinical study on safety and effectiveness |
| Scientific title | Effect of human neural stem cells on patients with moderate to severe early-onset Alzheimer's disease clinical study on safety and effectiveness |
| Primary sponsor | Shanghai Mental Health Center |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | Alzheimer’s disease |
| Interventions | Low Dose Group:Nasal drip of human neural stem cell preparations;Middle Dose Group:Nasal drip of human neural stem cell preparations;High Dose Group: Nasal drip of human neural stem cell preparations;Control Placebo Group:Nasal drip of… |
| Registration date | Oct 13, 2020 |
| Target size | Low Dose Group:9;Middle Dose Group:9;High Dose Group:9;Control Placebo Group:9 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: